Anti-GSK3 alpha antibody [EP793Y]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
4
(1 Review)
|
(17 Publications)
Rabbit Recombinant Monoclonal GSK3 alpha antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 17 publications.
View Alternative Names
Glycogen synthase kinase-3 alpha, GSK-3 alpha, Serine/threonine-protein kinase GSK3A, GSK3A
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GSK3 alpha antibody [EP793Y] (AB40870)
ab4870 at 1/50 dilution, staining GSK3 alpha in Human breast carcinoma tissue by Immunohistochemistry, Paraffin embedded section.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-GSK3 alpha antibody [EP793Y] (AB40870)
Immunocytochemistry/ Immunofluorescence analysis of HeLa (human cervix adenocarcinoma epithelial cell) cells labeling GSK3 alpha with purified ab40870 at 1/200 dilution (10 μg/mL). Cells were fixed in 100% Methanol. Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/mL) dilution. DAPI (blue) was used as nuclear counterstain.
- WB
Lab
Western blot - Anti-GSK3 alpha antibody [EP793Y] (AB40870)
Lanes 1-4 : Merged signal (red and green). Green - ab40870 observed at 51 kDa. Red - loading control ab8245 observed at 36 kDa.
ab40870 Anti-GSK3 alpha antibody [EP793Y] was shown to specifically react with GSK3 alpha in wild-type HEK-293T cells. Loss of signal was observed when knockout cell line ab266742 (knockout cell lysate ab257979) was used. Wild-type and GSK3 alpha knockout samples were subjected to SDS-PAGE. ab40870 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-GSK3 alpha antibody [EP793Y] (ab40870) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 20 µg
Lane 2:
Western blot - Human GSK3A (GSK3 alpha) knockout HEK-293T cell lysate (<a href='/en-us/products/cell-lysates/human-gsk3a-gsk3-alpha-knockout-hek-293t-cell-lysate-ab257979'>ab257979</a>) at 20 µg
Lane 3:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 4:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 51 kDa
Observed band size: 51 kDa
false
- WB
Supplier Data
Western blot - Anti-GSK3 alpha antibody [EP793Y] (AB40870)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : GSK3 alpha knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lane 4 : HepG2 whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab40870 observed at 51 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab40870 was shown to specifically react with GSK3 alpha in wild-type HAP1 cells. No band was observed when GSK3 alpha knockout samples were examined. Wild-type and GSK3 alpha knockout samples were subjected to SDS-PAGE. ab40870 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at a 1/5000 dilution and 1/10,000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-GSK3 alpha antibody [EP793Y] (ab40870)
Predicted band size: 51 kDa
false
- WB
Unknown
Western blot - Anti-GSK3 alpha antibody [EP793Y] (AB40870)
All lanes:
Western blot - Anti-GSK3 alpha antibody [EP793Y] (ab40870) at 1/5000 dilution
All lanes:
10ug HeLa cell lysate.
Predicted band size: 51 kDa
Observed band size: 51 kDa
false
Related conjugates and formulations (1)
-
Anti-GSK3 alpha antibody [EP793Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
GSK3 alpha influences several cellular functions including cell division differentiation and apoptosis. It functions independently or as part of a protein complex often forming dimeric complexes with GSK3 beta. GSK3 alpha alters the activity of numerous transcription factors and regulates insulin and Wnt signaling pathways affecting glucose metabolism and cellular growth.
Pathways
GSK3 alpha is involved in the Wnt and insulin signaling pathways. In the Wnt pathway GSK3 alpha phosphorylates beta-catenin marking it for degradation and controlling gene expression. In the insulin pathway it modulates glycogen synthesis and affects glucose homeostasis. GSK3 alpha interacts closely with proteins like APC and glycogen synthase making it integral to these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:8857 PubMed41053170
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:229 PubMed38509077
2024
Applications
Unspecified application
Species
Unspecified reactive species
Emerging microbes & infections 11:391-405 PubMed34985411
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:763181 PubMed34955834
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:20738-20747 PubMed34453028
2021
Applications
Unspecified application
Species
Unspecified reactive species
Human molecular genetics 30:2347-2361 PubMed34270708
2021
Applications
Unspecified application
Species
Unspecified reactive species
Respiratory research 22:146 PubMed33980216
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of molecular medicine (Berlin, Germany) 99:831-844 PubMed33609145
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 20:219 PubMed32963625
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 13:81 PubMed32581704
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com